153 related articles for article (PubMed ID: 18478927)
21. RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells.
Wu M; Wu ZF; Kumar-Sinha C; Chinnaiyan A; Merajver SD
Breast Cancer Res Treat; 2004 Mar; 84(1):3-12. PubMed ID: 14999149
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
[TBL] [Abstract][Full Text] [Related]
23. Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC.
Wu D; Asiedu M; Wei Q
Oncogene; 2009 Jun; 28(22):2219-30. PubMed ID: 19421144
[TBL] [Abstract][Full Text] [Related]
24. [Screening of phosphoprotein associated with glycosphingolipid microdomains 1 (PAG1) by cDNA microarray and influence of overexpression of PAG1 on biologic behavior of human metastatic prostatic cancer cell line in vitro].
Yu WJ; Wang YW; Xie ZG; You JF; Wang JL; Cui XL; Pei F; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):88-94. PubMed ID: 20388373
[TBL] [Abstract][Full Text] [Related]
25. Terrein inhibits migration of human breast cancer cells via inhibition of the Rho and Rac signaling pathways.
Kasorn A; Loison F; Kangsamaksin T; Jongrungruangchok S; Ponglikitmongkol M
Oncol Rep; 2018 Mar; 39(3):1378-1386. PubMed ID: 29328460
[TBL] [Abstract][Full Text] [Related]
26. RhoC upregulation is correlated with reduced E-cadherin in human breast cancer specimens after chemotherapy and in human breast cancer MCF-7 cells.
Kawata H; Kamiakito T; Omoto Y; Miyazaki C; Hozumi Y; Tanaka A
Horm Cancer; 2014 Dec; 5(6):414-23. PubMed ID: 25123151
[TBL] [Abstract][Full Text] [Related]
27. RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway.
Sun HW; Tong SL; He J; Wang Q; Zou L; Ma SJ; Tan HY; Luo JF; Wu HX
World J Gastroenterol; 2007 Jul; 13(25):3517-22. PubMed ID: 17659701
[TBL] [Abstract][Full Text] [Related]
28. A definitive role of RhoC in metastasis of orthotopic lung cancer in mice.
Ikoma T; Takahashi T; Nagano S; Li YM; Ohno Y; Ando K; Fujiwara T; Fujiwara H; Kosai K
Clin Cancer Res; 2004 Feb; 10(3):1192-200. PubMed ID: 14871999
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
Wang W; Wu F; Fang F; Tao Y; Yang L
Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
[TBL] [Abstract][Full Text] [Related]
30. [Expression of RhoC in gastric cancer cell lines and construction and identification of RhoC-specific siRNA expression vector].
Liu N; Bi F; Pan YL; Xue Y; Han ZY; Liu CJ; Fan DM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):148-51. PubMed ID: 15191713
[TBL] [Abstract][Full Text] [Related]
31. Antisense RhoC gene suppresses proliferation and invasion capacity of human QBC939 cholangiocarcinoma cells.
Shi Z; Chen ML; He QL; Zeng JH
Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):516-20. PubMed ID: 17897917
[TBL] [Abstract][Full Text] [Related]
32. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway.
Zhang K; Zhang M; Zhao H; Yan B; Zhang D; Liang J
Dis Esophagus; 2012; 25(8):731-9. PubMed ID: 22458600
[TBL] [Abstract][Full Text] [Related]
33. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
34. MiRNA-10b sponge: An anti-breast cancer study in vitro.
Liang AL; Zhang TT; Zhou N; Wu CY; Lin MH; Liu YJ
Oncol Rep; 2016 Apr; 35(4):1950-8. PubMed ID: 26820121
[TBL] [Abstract][Full Text] [Related]
35. Phosphatidylethanolamine-binding protein 4 is associated with breast cancer metastasis through Src-mediated Akt tyrosine phosphorylation.
Li H; Huang F; Fan L; Jiang Y; Wang X; Li J; Wang Q; Pan H; Sun J; Cao X; Wang X
Oncogene; 2014 Sep; 33(37):4589-98. PubMed ID: 24276246
[TBL] [Abstract][Full Text] [Related]
36. [Overexpression of NDRG1: relationship with proliferative activity and invasiveness of breast cancer cell line and breast cancer metastasis].
Wang Z; Liu Q; Chen Q; Zhu R; Zhu HG
Zhonghua Bing Li Xue Za Zhi; 2006 Jun; 35(6):333-8. PubMed ID: 16834906
[TBL] [Abstract][Full Text] [Related]
37. RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9.
Zhao Y; Zong ZH; Xu HM
Gynecol Oncol; 2010 Mar; 116(3):563-71. PubMed ID: 20022093
[TBL] [Abstract][Full Text] [Related]
38. Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma.
Shikada Y; Yoshino I; Okamoto T; Fukuyama S; Kameyama T; Maehara Y
Clin Cancer Res; 2003 Nov; 9(14):5282-6. PubMed ID: 14614010
[TBL] [Abstract][Full Text] [Related]
39. RhoC expression and head and neck cancer metastasis.
Islam M; Lin G; Brenner JC; Pan Q; Merajver SD; Hou Y; Kumar P; Teknos TN
Mol Cancer Res; 2009 Nov; 7(11):1771-80. PubMed ID: 19861405
[TBL] [Abstract][Full Text] [Related]
40. p38γ promotes breast cancer cell motility and metastasis through regulation of RhoC GTPase, cytoskeletal architecture, and a novel leading edge behavior.
Rosenthal DT; Iyer H; Escudero S; Bao L; Wu Z; Ventura AC; Kleer CG; Arruda EM; Garikipati K; Merajver SD
Cancer Res; 2011 Oct; 71(20):6338-49. PubMed ID: 21862636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]